Literature DB >> 31026357

Regulation of interleukin-1 beta secretion from macrophages via modulation of potassium ion (K+ ) channel activity.

Jing Wang1, Paul J Yannie2, Siddhartha S Ghosh1, Shobha Ghosh1,2.   

Abstract

A causal relationship exists between macrophage cholesterol levels and inflammation, for example, Interleukin-1β (IL-1β) secretion. A decrease in intracellular K+ is essential for inflammasome activation/IL-1β secretion and, herein, we examined the hypothesis that cellular cholesterol affects K+ -channel activity and K+ -efflux using mouse peritoneal macrophages (MPMs) and human/THP1 macrophages. An increase in cellular cholesterol led to a significant increase in K+ currents (> 350% in both MPM and THP1). Enhancing cholesterol efflux returned K+ currents back to basal levels with corresponding increase in intracellular K+ (11.2-14.5%) and reduced IL-1β secretion (32-62%). These data demonstrate a novel mechanism by which cellular cholesterol modulates inflammation/inflammasome via regulation of K+ -channel activity and intracellular K+ levels. Attenuation of IL-1β secretion by Nateglinide/Repaglinide further suggests involvement of Kir6 channels.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  K+ currents; K+ efflux; cholesterol efflux; foam cells; interleukin 1 beta

Mesh:

Substances:

Year:  2019        PMID: 31026357      PMCID: PMC6557664          DOI: 10.1002/1873-3468.13395

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  48 in total

1.  Isoform-specific localization of voltage-gated K+ channels to distinct lipid raft populations. Targeting of Kv1.5 to caveolae.

Authors:  J R Martens; N Sakamoto; S A Sullivan; T D Grobaski; M M Tamkun
Journal:  J Biol Chem       Date:  2000-12-13       Impact factor: 5.157

2.  Elevated extracellular [K+] inhibits death-receptor- and chemical-mediated apoptosis prior to caspase activation and cytochrome c release.

Authors:  G J Thompson; C Langlais; K Cain; E C Conley; G M Cohen
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

3.  Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals.

Authors:  Anna Gumieniczek; Hanna Hopkała; Jacek Roliński; Agnieszka Bojarska-Junak
Journal:  Pharmacol Res       Date:  2005-08       Impact factor: 7.658

4.  Effects of S21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients.

Authors:  R Assaloni; R Da Ros; L Quagliaro; L Piconi; A Maier; G Zuodar; E Motz; A Ceriello
Journal:  Diabetologia       Date:  2005-07-09       Impact factor: 10.122

5.  Increased cholesterol deposition, expression of scavenger receptors, and response to chemotactic factors in Abca1-deficient macrophages.

Authors:  Omar L Francone; Lori Royer; Germaine Boucher; Mehrdad Haghpassand; Ann Freeman; Dominique Brees; Robert J Aiello
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-14       Impact factor: 8.311

6.  Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia. Differential effects of plasma lipoproteins on monocyte function.

Authors:  K H Han; K O Han; S R Green; O Quehenberger
Journal:  J Lipid Res       Date:  1999-06       Impact factor: 5.922

7.  Mechanism of terfenadine block of ATP-sensitive K(+) channels.

Authors:  B J Zünkler; S Kühne; I Rustenbeck; T Ott
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

8.  Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release.

Authors:  J Michelle Kahlenberg; George R Dubyak
Journal:  Am J Physiol Cell Physiol       Date:  2003-12-24       Impact factor: 4.249

9.  IL-1 beta maturation: evidence that mature cytokine formation can be induced specifically by nigericin.

Authors:  D Perregaux; J Barberia; A J Lanzetti; K F Geoghegan; T J Carty; C A Gabel
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

10.  Differential interactions of nateglinide and repaglinide on the human beta-cell sulphonylurea receptor 1.

Authors:  Ann Maria K Hansen; Inge T Christensen; John Bondo Hansen; Richard D Carr; Frances M Ashcroft; Philip Wahl
Journal:  Diabetes       Date:  2002-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.